Skip to main content
padlock icon - secure page this page is secure

Antimicrobial Agent Based on Selenium Nanoparticles and Carboxymethyl Cellulose for the Treatment of Bacterial Infections

Buy Article:

$110.00 + tax (Refund Policy)

Our main objective was to analyse and study the effects of the synthesized composite based on selenium nanoparticles and carboxymethyl cellulose (Cekol), hereinafter denoted as SeNPs-Cekol. Firstly, physico-chemical properties of SeNPs-Cekol were characterized in greater detail (size of nanoparticles—from 50 to 150 nm; content of selenium—278 ppm; pH of composite—5.4–5.6; density—990–1010 kg/m3), together with assessment of its stability. In addition, the toxicity and mutagenicity on prokaryotic and eukaryotic cells was successfully evaluated. All of the tested bacterial strains were isolated from wound swabs of infectious patients (n = 300) and identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). These strains were consequently exposed to SeNPs-Cekol composite. Almost all of the bacterial strains (n = 63) exhibited inhibition zones larger than 5 mm (limit for sensitivity to antibiotics) after the application of the SeNPs-Cekol (300 μM). Furthermore, in some tested strains (n = 8 for gram positive (G +; n = 4 for gram negative (G )) even the inhibition zones larger than 12 mm (limit value for very sensitive bacteria to antibiotics) were observed. Overall, the effects of the composite were higher for the G + bacteria in comparison with G bacteria, which are generally more resistant to antimicrobial agents, due to their cell wall structure. Further, we found that mutagenicity of the SeNPs-Cekol was found to be negligible. Even, non-target toxicity tests towards eukaryotic cells did not show any significant inhibition of the cells growth compared to the control. Therefore, it can be concluded that SeNPs-Cekol could be considered to have a potential in treatment of bacterial infections.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: ANTIMICROBIAL; CLINICAL ISOLATES; COMPOSITE; INHIBITION; SYNTHESIS

Document Type: Research Article

Publication date: July 1, 2017

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more